Usefulness of &omega;-3 fatty acid supplementation in addition to mesalazine in maintaining remission in pediatric Crohn's disease: A double-blind, randomized, placebo-controlled study

doi:10.3748/wjg.v11.i45.7118

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 45

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6267)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

537

HTML

5269

Figures (1-1)

232

Tables (1-1)

229

Sum=6267

Dec 7, 2005 (publication date) through Jan 24, 2025

Times Cited of This Article

Times Cited (72)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Research

World J Gastroenterol. Dec 7, 2005; 11(45): 7118-7121
Published online Dec 7, 2005. doi: 10.3748/wjg.v11.i45.7118

Full Size Figure Download Figure

Figure 1 Relapses of CD after 1 yr (A), throughout the follow-up (B) and in those with ileo-colonic CD (C) (%). Characteristics of patients at the beginning of the study

Citation: Romano C, Cucchiara S, Barabino A, Annese V, Sferlazzas C, Diseases SISGOPIB. Usefulness of ω-3 fatty acid supplementation in addition to mesalazine in maintaining remission in pediatric Crohn's disease: A double-blind, randomized, placebo-controlled study. World J Gastroenterol 2005; 11(45): 7118-7121
URL: https://www.wjgnet.com/1007-9327/full/v11/i45/7118.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i45.7118